MannKind

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. 

CEO
Michael E. Castagna
CEOMichael E. Castagna
Employees
407
Employees407
Headquarters
Danbury, Connecticut
HeadquartersDanbury, Connecticut
Founded
1991
Founded1991
Employees
407
Employees407

MNKD Key Statistics

Market cap
1.14B
Market cap1.14B
Price-Earnings ratio
39.12
Price-Earnings ratio39.12
Dividend yield
Dividend yield
Average volume
2.45M
Average volume2.45M
High today
$3.92
High today$3.92
Low today
$3.74
Low today$3.74
Open price
$3.92
Open price$3.92
Volume
2.32M
Volume2.32M
52 Week high
$7.63
52 Week high$7.63
52 Week low
$3.51
52 Week low$3.51

MNKD News

TipRanks 3d
MannKind assumed with a Buy at H.C. Wainwright

H.C. Wainwright assumed coverage of MannKind (MNKD) with a Buy rating and $9 price target The firm views the company’s pipeline as largely overlooked at current...

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MNKD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.